MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, LONA had -$36,443K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$36,443K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Change in fair value of sermonix...
    • Maturities of available-for-sale...
    • Stock-based compensation
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of available-for-sale ...
    • Accounts payable and accrued lia...
    • Others

Cash Flow
2026-03-31
2025-12-31
Net loss
-32,948 -105,609
Non-cash consideration for acquired in-process research and development
-67,659
Milestone liability change in fair value
-929 -
Change in fair value of sermonix pre-funded warrant
16,320 4,579
Stock-based compensation
662 6,102
Depreciation expense
231 972
Non-cash lease expense
74 273
Amortization of premiums and accretion of discounts on available-for-sale securities, net
260 329
Prepaid expenses and other current and long-term assets, net
396 -2,439
Accounts payable and accrued liabilities
-3,362 -21,342
Operating lease liability
-112 -414
Other long-term liabilities
-183 -59
Net cash used in operating activities
-20,903 -45,729
Purchases of available-for-sale securities
20,615 37,643
Maturities of available-for-sale securities
5,075 21,749
Net cash (used in) provided by investing activities
-15,540 -15,894
Proceeds from exercise of common stock options and issuance of common stock under employee stock purchase plan
-37
Proceeds from pipe financing
-89,991
Issuance costs from pipe financing
-7,567
Net cash provided by financing activities
-82,461
Net increase (decrease) in cash, cash equivalents and restricted cash
-36,443 20,838
Cash, cash equivalents and restricted cash, beginning of period
69,907 49,069
Cash, cash equivalents and restricted cash, end of period
33,464 69,907
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net increase(decrease) in cash, cash...-$36,443K Change in fair value ofsermonix pre-funded...$16,320K Stock-based compensation$662K Depreciation expense$231K Non-cash lease expense$74K Maturities ofavailable-for-sale securities$5,075K Net cash used inoperating activities-$20,903K Net cash (used in)provided by investing...-$15,540K Canceled cashflow$17,287K Canceled cashflow$5,075K Net loss-$32,948K Purchases ofavailable-for-sale securities$20,615K Accounts payable andaccrued liabilities-$3,362K Milestone liabilitychange in fair value-$929K Prepaid expenses andother current and...$396K Amortization of premiums andaccretion of discounts on...$260K Other long-termliabilities-$183K Operating lease liability-$112K

LeonaBio, Inc. (LONA)

LeonaBio, Inc. (LONA)